ARENA PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
29 Jul 2021	Form 3: Manion Douglas J., EVP Research & Development No securities owned
15 Jun 2021	Form 3: Schoch Steven J, Director No securities owned
11 Mar 2021	Form 3: Arena Pharmaceuticals Inc, 10% owner · Longboard Pharmaceuticals, Inc. Holds 3,840,540 shares of Voting Common Stock
18 Feb 2021	Form 3: Ouzren Nawal, Director No securities owned
16 Jun 2020	Form 3: Knobil Katharine, Director Holds 85 shares of Common Stock
16 Jun 2020	Form 3: Cabell Christopher, EVP, Head of R&D, and CMO
17 Mar 2020	Form 3: Stelzer Laurie, EVP & Chief Financial Officer No securities owned
03 Mar 2020	Form 3: Schmidt Joan, EVP, General Counsel & Sec No securities owned
20 Jun 2019	Form 3: Lisicki Robert, EVP, Chief Commercial Officer
17 Dec 2018	Form 3: Soni Manmeet Singh, Director No securities owned
10 Jul 2018	Form 3: Gallahue Kieran, Director No securities owned
14 Jun 2017	Form 3: Jarrett Jennifer, Director No securities owned
20 Mar 2017	Form 3: Klassen Preston, EVP and CMO No securities owned
14 Feb 2017	Form 3: Neil Garry Arthur, Director No securities owned
14 Feb 2017	Form 3: Fetzer Oliver, Director No securities owned
14 Feb 2017	Form 3: Dallas Jayson Donald Alexander, Director No securities owned
15 Aug 2016	Form 3: Aurentz Vincent, Executive VP and CBO No securities owned
15 Jun 2016	Form 3: Lind Kevin Robert, Executive VP and CFO No securities owned
11 May 2016	Form 3: Munshi Amit, President and CEO No securities owned
18 Dec 2015	Form 3: Mezzino Maurice James, SVP, Corporate Development Holds 8,763 shares of Common Stock

Comments